BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32370731)

  • 1. Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study.
    El-Nahas MR; Elkannishy G; Abdelhafez H; Elkhamisy ET; El-Sehrawy AA
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1531-1534. PubMed ID: 32370731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
    Ziegler D; Gries FA
    Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
    Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
    Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie.
    Ziegler D; Schatz H; Conrad F; Gries FA; Ulrich H; Reichel G
    Diabetes Care; 1997 Mar; 20(3):369-73. PubMed ID: 9051389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy.
    Pieralice S; Vari R; Minutolo A; Maurizi AR; Fioriti E; Napoli N; Pozzilli P; Manfrini S; Maddaloni E
    Endocrine; 2019 Nov; 66(2):178-184. PubMed ID: 30949911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial.
    Won JC; Kwon HS; Moon SS; Chun SW; Kim CH; Park IB; Kim IJ; Lee J; Cha BY; Park TS
    Diabetes Metab J; 2020 Aug; 44(4):542-554. PubMed ID: 31701699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
    Didangelos T; Karlafti E; Kotzakioulafi E; Kontoninas Z; Margaritidis C; Giannoulaki P; Kantartzis K
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
    Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
    J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review.
    Hsieh RY; Huang IC; Chen C; Sung JY
    Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus.
    Shehab D; Al-Jarallah K; Abdella N; Mojiminiyi OA; Al Mohamedy H
    Med Princ Pract; 2015; 24(3):250-6. PubMed ID: 25720672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of the intravenous administration of the trometamol salt of thioctic (alpha-lipoic) acid in diabetic neuropathy].
    Strokov IA; Kozlova NA; Mozolevskiĭ IuV; Miasoedov SP; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(6):18-22. PubMed ID: 10441861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.
    Agathos E; Tentolouris A; Eleftheriadou I; Katsaouni P; Nemtzas I; Petrou A; Papanikolaou C; Tentolouris N
    J Int Med Res; 2018 May; 46(5):1779-1790. PubMed ID: 29517942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
    Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
    Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
    Ruhnau KJ; Meissner HP; Finn JR; Reljanovic M; Lobisch M; Schütte K; Nehrdich D; Tritschler HJ; Mehnert H; Ziegler D
    Diabet Med; 1999 Dec; 16(12):1040-3. PubMed ID: 10656234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea extract for mild-to-moderate diabetic peripheral neuropathy A randomized controlled trial.
    Essmat A; Hussein MS
    Complement Ther Clin Pract; 2021 May; 43():101317. PubMed ID: 33517103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.